ORTIN GLOBAL Latest Share Price (ORTINGLOBE)
TODAY IN ONE LINE
ORTINGLOBE jumped 4.8% on above-average volume (839530.4x avg), outperforming Nifty's -0.3% move, with no exchange filing today, suggesting a market-driven move.
With a market cap of ₹13.72 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
ORTIN GLOBAL flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Price MomentumStock underperformed, dropping 15.6% over 1Y
- ●Sales ContractionQuarterly sales dropped 66.3% YoY
- ●Low Promoter HoldingPromoters hold only 1.2%
Latest ORTIN GLOBAL News
What changed recently?
Recent events, corporate actions, and announcements.
ORTIN GLOBAL valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for ORTIN GLOBAL, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
ORTIN GLOBAL technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for ORTIN GLOBAL — derived from the latest tape, not yesterday's close.
ORTIN GLOBAL last traded at ₹17.09 with an intraday range of ₹15.81–₹17.11 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹17.09| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 20.13 | +3.04 | +17.79% |
| R3 | 18.83 | +1.74 | +10.18% |
| R2 | 17.97 | +0.88 | +5.15% |
| R1 | 17.53 | +0.44 | +2.57% |
| PIVOT | 16.67 | -0.42 | -2.46% |
| CURRENT | 17.09 | — | — |
| S1 | 16.23 | -0.86 | -5.03% |
| S2 | 15.37 | -1.72 | -10.06% |
| S3 | 14.93 | -2.16 | -12.64% |
| S4 | 13.63 | -3.46 | -20.25% |
ORTINGLOBE is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹15.81–₹17
Trading Above opening range, showing Bullishness
ORTIN GLOBAL financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for ORTIN GLOBAL — consolidated or standalone — with margins, YoY growth and key ratios inline.
ORTIN GLOBAL reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹13.72 Cr. and reported EPS of ₹-0.42.
ORTIN GLOBAL segment analysis : revenue and profit mix.
Disclosed business segments at ORTIN GLOBAL with their share of revenue and profit, switchable between consolidated and standalone reporting.
ORTIN GLOBAL discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for ORTIN GLOBAL.
Our AI distills the core fundamental drivers supporting ORTIN GLOBAL, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
ORTIN GLOBAL's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.31. Balance sheet risk re-prices growth multiples fast.
ORTIN GLOBAL peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — ORTIN GLOBAL is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
ORTIN GLOBAL chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for ORTIN GLOBAL — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
ORTIN GLOBAL delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for ORTIN GLOBAL over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in ORTIN GLOBAL stood at 76.7% of traded volume, against a 20-day average of 83.6%.
ORTIN GLOBAL announcements: results, concalls, ratings, M&A.
Filings ORTIN GLOBAL sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
ORTIN GLOBAL files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 45 documents below.
Resignation of Director/KMP/SMP
ORTIN GLOBAL LIMITED has informed the Exchange about Resignation of Director/KMP/SMP
Shareholders meeting
ORTIN GLOBAL LIMITED has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
Change in Director(s)
ORTIN GLOBAL LIMITED has informed the Exchange regarding Change in Director(s) of the company.
Outcome of Board Meeting
ORTIN GLOBAL LIMITED has informed the Exchange regarding Outcome of Board Meeting held on September 07, 2026.
Outcome of Board Meeting
ORTIN GLOBAL LIMITED has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
ORTIN GLOBAL dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue ORTIN GLOBAL has declared, sequenced by announce and record date.
ORTIN GLOBAL corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About ORTIN GLOBAL: business, sector, key facts.
What ORTIN GLOBAL does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
ORTIN GLOBAL operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: ORTINGLOBE, BSE: 539287.
Ortin Global Limited is a pharmaceutical company based in Hyderabad, India, established in 1986 and rebranded in June 2024. Its primary business revolves around the manufacture and trade of pharmaceuticals, drugs, and their intermediate components within the Indian market and potentially for export.
The company operates through two main segments: manufacturing and trading. The manufacturing segment focuses on a wide array of pharmaceutical formulations, encompassing various therapeutic categories. These include tablets, capsules, syrups, and dry powders targeting conditions such as diabetes, allergies, cardiovascular issues, infections (bacterial, fungal, parasitic), pain, and gastrointestinal problems. Their product portfolio also extends to psychiatric medications, nutritional supplements (vitamins, proteins, enzymes), and anti-retroviral drugs.
Beyond finished formulations, Ortin Global also manufactures active pharmaceutical ingredients (APIs) and their intermediates. This vertical integration allows them to control a significant portion of their supply chain. The APIs manufactured include those used in anti-retrovirals, diabetes treatments, pain relievers, antibiotics, antifungals, antacids, and anti-malarial drugs. They also produce fine chemicals and organometallic compounds like Grignard reagents.
Complementing its manufacturing capabilities, Ortin Global provides a range of research and development services. These services encompass process development and optimization, product characterization, analytical testing (assay development), and formulation development for new brands. Furthermore, they offer diagnostic services including the development of rapid diagnostic kits and reagents. The company also undertakes long-term contracts for the custom manufacturing of intermediates and the development of new APIs.
In addition to its core pharmaceutical operations, Ortin Global engages in the export of finished pharmaceutical formulations and holds real estate assets. The company’s diversified business model combines manufacturing, trading, research and development, and real estate holdings, contributing to its overall revenue streams.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AAREY DRUGS & PHARM (AAREYDRUGS) Share PricePeer
- AARTI DRUGS (AARTIDRUGS) Share PricePeer
- AARTI PHARMALABS (AARTIPHARM) Share PricePeer
- AJANTA PHARMA (AJANTPHARM) Share PricePeer
- AKUMS DRUGS AND PHARMA L (AKUMS) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about ORTIN GLOBAL (ORTINGLOBE).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of ORTIN GLOBAL (ORTINGLOBE)?
The current share price of ORTIN GLOBAL (ORTINGLOBE) is ₹17.09. Today, the stock has gained by ₹0.79 (4.85%), trading in a range of ₹15.81 to ₹17.11. The stock opened at ₹16.70 with a trading volume of 30,391 shares.
02What is the 52-week high and low price of ORTIN GLOBAL stock?
The 52-week high price of ORTIN GLOBAL (ORTINGLOBE) is ₹21.30, while the 52-week low is ₹11.00. Currently trading at ₹17.09, the stock is 55.36% above its 52-week low and 19.77% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
03What is the dividend yield of ORTIN GLOBAL and when is the next dividend?
ORTIN GLOBAL offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹17.09, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
04How is ORTIN GLOBAL stock performing today in the market?
ORTIN GLOBAL stock opened at ₹16.70 and is currently trading at ₹17.09, showing a gain of ₹0.79 (4.85%). The intraday high is ₹17.11 and low is ₹15.81. The trading volume stands at 30,391 shares, indicating moderate market participation today.
05What is the market capitalization of ORTIN GLOBAL?
ORTIN GLOBAL has a market capitalization of ₹13.72 Cr., making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹17.09) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
06What is the ROE and ROCE of ORTIN GLOBAL?
ORTIN GLOBAL has a Return on Equity (ROE) of -59.85% and Return on Capital Employed (ROCE) of -44.08%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
07Which sector and industry does ORTIN GLOBAL belong to?
ORTIN GLOBAL operates in the Healthcare sector and belongs to the Pharmaceuticals industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
08What is the debt-to-equity ratio of ORTIN GLOBAL?
ORTIN GLOBAL has a debt-to-equity ratio of 0.81, which measures the company's financial leverage by comparing total debt to shareholders' equity. This moderate ratio indicates balanced use of debt and equity. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
The data, ratios and commentary about ORTIN GLOBAL (ORTINGLOBE) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.